Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:15 pm Sale | 2025-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL MANAGEMENT, LLC | 6,717,825 8.400% | -1,093,935 (-14.00%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | EVOLUS INC EOLS | TANG CAPITAL MANAGEMENT, LLC | 4,997,399 7.900% | 150,000 (+3.09%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | JOURNEY MED CORP COM DERM | TANG CAPITAL MANAGEMENT, LLC | 1,854,596 8.000% | 330,658 (+21.70%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL MANAGEMENT, LLC | 4,941,798 9.900% | 620,251 (+14.35%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | TANG CAPITAL MANAGEMENT, LLC | 1,900,000 5.600% | 1,900,000 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL MANAGEMENT, LLC | 195,515 7.800% | 195,515 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | ADICET BIO INC ACET | TANG CAPITAL MANAGEMENT, LLC | 513,976 9.900% | 416 (+0.08%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | ELEVATION ONCOLOGY INC ELEV | TANG CAPITAL MANAGEMENT, LLC | 6,043,921 9.990% | 6,043,921 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-05-13 | 13G | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 3,604,976 (+1625.94%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | PRECISION BIOSCIENCES INC DTIL | TANG CAPITAL MANAGEMENT, LLC | 673,332 6.400% | 50,000 (+8.02%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL MANAGEMENT, LLC | 2,454,797 5.900% | 2,454,797 (New Position) | Filing History |
| 2025-05-02 4:15 pm Purchase | 2025-05-02 | 13D | HILLEVAX INC HLVX | TANG CAPITAL MANAGEMENT, LLC | 4,920,000 9.800% | 4,920,000 (New Position) | Filing History |
| 2025-05-01 4:15 pm Purchase | 2025-04-24 | 13G | SPYRE THERAPEUTICS, INC SYRE | TANG CAPITAL MANAGEMENT, LLC | 3,200,000 5.300% | 3,200,000 (New Position) | Filing History |
| 2025-04-17 4:01 pm Unchanged | 2025-04-15 | 13D | ALLAKOS INC ALLK | TANG CAPITAL MANAGEMENT, LLC | 8,693,687 9.600% | 0 (Unchanged) | Filing History |
| 2025-04-04 6:57 pm Purchase | 2025-03-28 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | TANG CAPITAL MANAGEMENT, LLC | 2,178,609 5.200% | 2,178,609 (New Position) | Filing History |
| 2025-04-03 4:40 pm Purchase | 2025-04-01 | 13D | ALLAKOS INC ALLK | TANG CAPITAL MANAGEMENT, LLC | 8,693,687 9.600% | 247 (+0.00%) | Filing History |
| 2025-03-12 5:58 pm Purchase | 2025-03-10 | 13D | ACELYRIN INC SLRN | TANG CAPITAL MANAGEMENT, LLC | 8,824,693 8.800% | 1,526,365 (+20.91%) | Filing History |
| 2025-03-10 5:24 pm Purchase | 2025-03-03 | 13D | PLIANT THERAPEUTICS INC PLRX | TANG CAPITAL MANAGEMENT, LLC | 5,859,044 9.600% | 5,859,044 (New Position) | Filing History |
| 2025-03-04 5:04 pm Purchase | 2025-02-28 | 13D | AURINIA PHARMACEUTICALS INC AUPH | TANG CAPITAL MANAGEMENT, LLC | 10,029,500 7.300% | 2,800,000 (+38.73%) | Filing History |
| 2025-02-27 7:02 pm Purchase | 2025-02-25 | 13D | ACELYRIN INC SLRN | TANG CAPITAL MANAGEMENT, LLC | 7,298,328 7.300% | 2,000,000 (+37.75%) | Filing History |